The functional activity of Peptide YY3 relies on the intricate modulation of intracellular second messengers, specifically cyclic adenosine monophosphate (cAMP). Activation of adenylyl cyclase plays a pivotal role in this process, a mechanism employed by certain compounds which results in an upsurge of cAMP synthesis. This amplification of the cAMP signaling cascade directly enhances Peptide YY3 activity through the activation of downstream effectors. Moreover, the preservation of elevated cAMP levels is achieved through the inhibition of phosphodiesterases, an action that sustains and prolongs the activation signal for Peptide YY3. By preventing the degradation of cAMP, these inhibitors ensure the continued stimulation of the associated signaling pathways, thereby maintaining the active state of Peptide YY3.
Further contributing to the activity of Peptide YY3 are agents that interact with G-protein-coupled receptors, initiating a sequence of events that culminate in the activation of adenylyl cyclase and subsequent cAMP accumulation. This interaction triggers a cascade that leads to the activation of Peptide YY3, highlighting the importance of receptor-mediated cellular communication in the modulation of its activity. Additionally, the modulation of cAMP and cGMP levels through other molecular mechanisms serves to fine-tune the signaling environment conducive to Peptide YY3 activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, which prevents cAMP degradation, thereby sustaining the activation signal for Peptide YY3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that stimulates adenylyl cyclase activity, thus increasing cAMP concentrations and promoting Peptide YY3 activity. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Specific inhibitor of phosphodiesterase 3, leading to increased cAMP levels, which supports the activation of Peptide YY3. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Phosphodiesterase 3 inhibitor that raises intracellular cAMP, facilitating the activation of Peptide YY3 through enhanced signal transduction. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective inhibitor of phosphodiesterase 4, increasing cAMP levels and thereby potentiating the activation of Peptide YY3. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibitor of phosphodiesterases 5, 6, and 9, leading to increased cAMP and cGMP levels, which can augment the activation of Peptide YY3. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Inhibits phosphodiesterase 3, resulting in elevated cAMP levels and consequent activation of Peptide YY3 signaling pathways. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Activates G-protein-coupled receptors that stimulate adenylyl cyclase, increasing cAMP levels and promoting Peptide YY3 signaling. | ||||||